Dr. James Paul Swearingen Jr., MD

Dr. Swearingen practices at WK Pierremont Eye Institute in Shreveport, Louisiana.

Dr. Swearingen's NPI, 1003878075, was assigned on April 5, 2006. Dr. Swearingen graduated from Louisiana State University School of Medicine in Shreveport in 1975. Dr. Swearingen holds Louisiana license MD.013332.

Dr. Swearingen's primary practice is WK Pierremont Eye Institute, at 7607 Youree Dr, Shreveport, LA 71105 in Caddo Parish. The practice phone is (318) 212-6307.

Dr. Swearingen's primary practice is WK Pierremont Eye Institute in Shreveport, Louisiana. Dr. Swearingen is also affiliated with Willis Knighton North. Dmand AI also links Dr. Swearingen to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Swearingen practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Swearingen's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Swearingen is licensed in Louisiana.

Dmand AI lists age-related macular degeneration, cataract, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Swearingen treats.

CMS data shows 1,377 Medicare services from Dr. Swearingen across 12 procedure codes in 2024, for 679 Medicare patients. Medicare paid $77,841 for them. Every service was in an office.

CMS counts 679 Medicare patients who saw Dr. Swearingen in 2024. The largest group is 65 to 74, with 308 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Swearingen's median patient age at 70, with 61% women.

In 2024, Dr. Swearingen wrote 244 Medicare Part D claims for 95 patients. 46% of them were for generic drugs. CMS names the drug for 178 of them, across 7 drugs with 11 or more claims each, at $21,622 in total drug cost. In 2023, CMS named 208 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Swearingen for performance year 2024, reported through an alternative payment model (APM). Dr. Swearingen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 76 procedures of cataract surgery by Dr. Swearingen, more than 70% of the clinicians it reports for that procedure.

CMS Open Payments shows 199 general payments to Dr. Swearingen from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Alcon Laboratories Inc paid the most, $728.

Dr. Swearingen graduated from Louisiana State University School of Medicine in Shreveport in 1975.

Dr. Swearingen is in network with 12 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.